Misek, S. A. http://orcid.org/0000-0002-0246-5018
Appleton, K. M.
Dexheimer, T. S.
Lisabeth, E. M.
Lo, R. S.
Larsen, S. D.
Gallo, K. A.
Neubig, R. R. http://orcid.org/0000-0003-0501-0008
Article History
Received: 20 March 2019
Revised: 25 September 2019
Accepted: 14 October 2019
First Online: 28 October 2019
Compliance with ethical standards
:
: RRN and SDL have intellectual property rights in the CCG-222740 compound used in this study. They are also founders and officers of FibrosIX Inc. which has an option for the IP for this and related compounds. The remaining authors declare that they have no conflict of interest.